Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Announcement of a Change in Shareholding According to Chapter 9, Section 10 of the Finnish Securities Market Act

Sitowise Group Plc Stock Exchange Release 8 November 2024 at 9.45 a.m. (EET) Sitowise Group Plc (the "Company") has on 7 November 2024 received a notification in accordance with the Chapter 9, Section 10 of the Finnish Securities Market Act from Morgan Stanley, according to which Morgan Stanley & Co International Plc's holding of the shares and votes of the Company is above 5.00 percent on 6 November 2024. According to the notification, Morgan Stanley holds indirectly a total of 46,475 shares corresponding to 0,13 percent of the Company’s shares and votes, and a total of 2,456,506

Webstep ASA: Exercise window for share options

Oslo, 8 November 2024: With reference to the stock exchange announcement by Webstep ASA (the “Company”) of 18 November 2019, in which it was announced that Webstep ASA granted employee share options as part of the Company’s long-term incentive programme (“LTIP”).The Company will conduct a window on 14 November - 15 November 2024, in which the option holders may exercise share options. The total amount of vested options is 310,361 options, of which 122,461 options are in the money as of 8 November 2024 and exercisable for the option holders.

Italian leak detection systems manufacturer has become part of Atlas Copco Group

Nacka, Sweden, November 8, 2024: The acquisition of ESA Service S.r.l, (“ESA Service”), a company designing and manufacturing leak detection and gas recovery systems, has been completed and the company has become part of Atlas Copco Group.ESA Service is headquartered at its manufacturing location in Treviglio, Italy. The company has 40 employees and in 2023 revenues amounted to 10.3 MEUR (MSEK 118*). The purchase price is not disclosed. The company has become part of the Scientific Vacuum division within the Vacuum Technique Business Area.

Biosergen publishes interim report for third quarter 2024

Friday November 8, 2024: Biosergen AB (“Biosergen” or the “Company”) hereby publishes the interim report for the third quarter 2024. The interim report is available as an attached document and on the company website (www.biosergen.net)     BIOSERGEN HAS COMPLETED FIRST PATIENT COHORTThe most significant recent result for Biosergen is the successful completion of the treatment of the first cohort of patients in our clinical trial for BSG005. The early data are remarkable, with some patients achieving complete recovery at a low dose of BSG005, while others experienced significant

Moberg Pharma’s Nomination Committee appointed

STOCKHOLM, November 8[th], 2024 – In accordance with the resolution of the Annual General Meeting on May 14[th], 2024, the Chairman of the Board has contacted the company’s two largest shareholders or group of shareholders in terms of votes to form a Nomination Committee. These shareholders have been invited to appoint one representative each who, together with the Chairman of the Board, will comprise the Nomination Committee. As not all of the company’s two largest shareholders or group of shareholders have wished to appoint such representative, the third largest shareholder/group of

Larger shareholder in Crunchfish fully subscribes for its pro rata share in the ongoing rights issue

Granitor Invest AB has announced the intention to subscribe for its pro rata share in the ongoing rights issue of units in Crunchfish AB (“Crunchfish” or the “Company”). In total 208,879 units will be subscribed for, corresponding to a subscription amount of SEK 0.6 million.NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL

Lea bank ASA (LEA): Mandatory notification of trade - primary insider

Rune Fjeldstad, Chairman of the board in Lea bank ASA, has purchased 56 511 shares in Lea bank ASA on 7 November 2024 at an average price per share of NOK 8,29. Following this transaction, Fjeldstad (including close associates) owns 112 274 shares in Lea bank ASA. Please see attached primary insider notification forms. This information is subject to the disclosure requirements in the Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities Trading Act. Contact information: Oddbjørn Berentsen, CEO Phone: +47 22 99 14 00 Email: ir@leabank.no

ArcticZymes Technologies - Primary insider trading

(Tromsø 08 November 2024) Frank Mathias, Chairman of the Board has on 07 November purchased 2.000 shares in ArcticZymes Technologies ASA for EUR 1.194 per share. Following this transaction holds Mr. Mathias 9.000 shares in the company.This information is subject to the disclosure requirements in articles 19 of the Regulation EU 596/2014 (the EU Market Abuse Regulation) and section 5-12 of the Norwegian Securities Trading Act. For additional information, please contactBørge SørvollCFO+4795290187ir@arcticzymes.com About ArcticZymes Technologies ASA ArcticZymes Technologies is

Interim Report Boho Group January – June 2024

Boho Group AB (publ) today publishes its interim report for the third quarter of 2024.EBITDA improved by 31% JULY - SEPTEMBER 2024 · Revenues from the company's operator business Boho Club amounted to SEK 41,037 thousand (37,331), corresponding to growth of 9.9%. Total revenue from operator business in the third quarter of 2023 of SEK 41,164 thousand also included revenue from the apartment hotel of SEK 4,120 thousand, which was discontinued in autumn 2023. · Income from the sale of properties during the period totalled SEK 13,220 thousand (22,940) and relates to the sale of

Fazer continues as a partner of the Finnish Tennis Association

Fazer and the Finnish Tennis Association have renewed their partnership agreement. The collaboration aims to encourage children and youth to play tennis while highlighting the importance of a balanced diet during critical growth years. Fazer is a partner in the Junior Grand Prix series, as well as major tennis events organised by the Finnish Tennis Association. The extension agreement is valid until the end of 2028.The nationally popular Junior Grand Prix series has carried the Fazer JGP series name since 2022. The Fazer Junior Grand Prix is played in age groups 10, 12, 14 and 16.   "

Norse Atlantic continues positive trend and records its highest ever load factor

October saw Norse Atlantic record its highest ever load factor for a month, achieving 90%, which represented a 15-percentage point (p.p.) year-on-year increase. During October, Norse Atlantic had 118,502 passengers, representing an increase of 16 per cent compared to a year earlier, across 410 flights, including 50 charters. Norse Atlantic completed 99 per cent of scheduled flights in the month, while 74 per cent of flights arrived within 15 minutes of their scheduled arrival time. “It is a pleasure to report our highest ever load factor in what is just under two and a half years since

Tezspire nasal polyps trial met primary endpoints

08 November 2024 Tezspire met both co-primary endpoints in the Phase III WAYPOINT trial in patientswith chronic rhinosinusitis with nasal polyps Tezspire demonstrated a statistically significant and clinically meaningful reduction innasal polyp size and reduced nasal congestion compared to placebo Positive high-level results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]) showed that AstraZeneca and Amgen's Tezspire (tezepelumab) demonstrated a statistically significant and clinically meaningful reduction in

Interim report January – September 2024

Stronger market position and increased profitJuly – September 2024 · Net sales amounted to SEK 392.0 million (262.9), an increase of 49%. · Net sales for comparable segments decreased by SEK 26.3 million, a decrease of 10%. · Operating profit amounted to SEK 32.2 million (28.0), an increase of 15%. · The operating margin decreased to 8.2% (10.7). · The profit for the period amounted to SEK 25.9 million (20.8), an increase of 25%. · Earnings per share, before dilution, amounted to SEK 1.24 (1.03) and after dilution to SEK 1.24 (0.99). · Cash flow from operating

Aurobay Wins Prestigious TECHNOBEST 2025 Award for Hybrid System Technology

Aurobay, a division of Horse Powertrain Limited, has won the TECHNOBEST 2025 award for its innovative Hybrid System technology. The award, presented by AUTOBEST, Europe's largest independent automotive jury representing 31 European countries, recognizes breakthrough achievements in automotive technology.Aurobay's Hybrid System Technology recently set new world records for range,fuel efficiency, and emissions, while offering substantial electric drivingcapability for urban use. The AUTOBEST jury acknowledged that althoughinternal combustion engines will continue to evolve, they remain

G2 Acquisition Inc. completes the public takeover offer to the shareholders and holders or warrants of series TO1 in ZignSec AB (publ)

Press release8 November 2024 On 4 September 2024, G2 Acquisition Inc. ("Offeror") announced a public takeover offer to the shareholders of ZignSec AB (publ) ("ZignSec") to acquire all outstanding shares in ZignSec at a price of SEK 1.38 in cash per share and SEK 1.13 in cash per warrant of series TO1 ("Offer"). The Offeror decided, after the initial acceptance period, to extend the acceptance period to 6 November 2024. The acceptance period has expired. As of 6 November 2024, the Offer has been accepted by holders of 195,473,803 shares, corresponding to approximately 94.6 percent of

Crunchfish signs license agreement with Precise Biometrics for XR Skeleton 3

Crunchfish Gesture Interaction and Precise Biometrics have entered into a long-term license agreement regarding XR Skeleton 3. The agreement will bring revenue to Crunchfish during eight years, based on Precise Biometrics’ sales of products that include XR Skeleton, starting 2025.[A person holding a cell phone Description automatically generated]   Crunchfish Gesture Interaction and Precise Biometrics have entered into a long-term license agreement regarding XR Skeleton 3. Precise Biometrics will include hand tracking from XR Skeleton in their next year release of a palm recognition

Polymer Factory Sweden AB (publ) Interim Report Q3 2024

The period in summary Third quarter, July-September 2024 · The patent application for the Company's dendritic nanogel platform (DNG) has been granted and issued by the US Patent and Trademark Office, USPTO · The Company has signed several Material Transfer Agreements (MTAs) regarding DNG Year to date, January-September 2024 · The Company entered into a distribution agreement regarding SpheriCal® · The Company has continued development of its technology platforms · The Company launched SpheriCal® for IM-MS · The Company exhibited and presented at the ASMS

Oneflow interim report Q3 2024: Shift towards profitability

Press release8 November 2024 Oneflow publishes its interim report for the third quarter of 2024: July - September 2024 (compared to the same period last year) · Net sales increased 40% to MSEK 35.7 (25.6). Share of Net sales outside Sweden increased to 37% (29) with paying customers in 41 countries. · EBIT was MSEK -15.5 (-22.7), with an EBIT margin of -43% (-89). · Net income for the period amounted to -15.4 (-22.0). · Basic earnings per share amounted to SEK -0.57 (-0.88) and diluted to SEK -0.57 (-0.88). · Total ARR YoY increased 34% to MSEK 155.8 (116.2). Net

Interim Report January-September 2024

Our Best Quarter in the Enzyme Business: Strong Growth and improved profitability July – September 2024 · Genovis executed a strategic acquisition of a 25% stake in Sequrna AB · Genovis successfully completed a strategic divestment of its Antibody Business to Leinco Technologies Inc. · Net sales totaled SEK 32,895 (30,186) thousand, with a growth rate of 9%. Adjusted for currency effects, the growth was 13%. Net sales for the enzyme business (excluding the antibody business) amounted to SEK 31,625 (25,426) thousand, reflecting a 24% growth, or 28% when adjusted for currency

Peab builds crematorium in Västerås

Peab has been commissioned to build a new crematorium at Hovdestalund in Västerås. The customer is the Church of Sweden and the contract is worth SEK 190 million.Peab has been commissioned to build a new crematorium building at Hovdestalund Cemetery formed to meet current conditions and environmental requirements. The new building will consist of several interconnecting sections on three floors with attendant visitor functions and staff rooms. The area is located in a protected environment and the building will be behind trees on a slope. While building the new crematorium building a new

Orthex to publish January−September 2024 Interim Report on Friday, 15 November 2024

Orthex Corporation, Press release, 8 November 2024 at 9.00 a.m. EETOrthex will publish its Interim Report for the period January−September 2024 on Friday, 15 November 2024 at around 9.00 a.m. EET. Following the publication, the report will be available in pdf-format on the corporate website at https://investors.orthexgroup.com/.Orthex’s CEO Alexander Rosenlew, CFO Saara Mäkelä and CMSO Hanna Kukkonen will present the report on the same day at 11.00 a.m. EET in a webcast. The webcast can be joined through this link . The result presentation will be

Interim report Image Systems AB January - September 2024

Favorable factors result in an exceptional third quarter The Group is ending an exceptionally strong quarter, with several favorable factors contributing. Both business units have delivered on the solid order backlog from the start of the quarter which has resulted in a considerable increase in both net sales and operating profit. However, we assess that the outcome for the third quarter is not yet a level to count on. The sawmill industry continues to be characterized by uncertainties. Thanks to streamlining measures and a focus on efficient solutions for customers, the RemaSawco business

There are no items matching the current filter
There are no more items matching the current filter
Back to top